Drug Type Small molecule drug |
Synonyms Compound B19 |
Target |
Mechanism NSUN3 inhibitors(NOP2/Sun RNA methyltransferase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H9N5O3S |
InChIKeyUQIHIFJLHVPGPK-UHFFFAOYSA-N |
CAS Registry2983087-66-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rectal Cancer | Preclinical | CN | 25 Jul 2024 |